NSE: HSCL | BSE: 500184

Mid-range Performer

Download real time

470.90 -5.85 (-1.23%)

28.89% Gain from 52W Low

790.5K NSE+BSE Volume

NSE 09 Jan, 2026 3:31 PM (IST)

23,757.8

Market Cap

High in industry

Beta 1Year

Very High Volatility

Board Meeting

The next board meeting for Himadri Speciality is on 16 Jan 2026 for the purpose of Quarterly Results See details

Himadri Speciality Chemical Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for HSCL, BSE:500184 Himadri Speciality Chemical Ltd.

Search Inside the pdf :

Himadri Speciality Chemical Ltd.

19 Jul 2025

470.90

-1.23%

EBITDA/kg continues to surprise positively

Hold: Himadri Speciality Chemica...

Target

ICICI Securities Limited

Himadri Specialty Chemical’s (Himadri) Q1FY26 volume rose only 0.7% YoY, probably on capacity constraints, but product mix improvement and EBITDA/kg continued to surprise positively (up 26.8% YoY).

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Himadri Speciality Chemical Ltd.

21 Apr 2020

470.90

-1.23%

Himadri Speciality

Hold: Himadri Speciality Chemica...

Recommendation Target

ICICI Securities Limited

Building in the prevailing muted demand prospects both domestically as well as globally in its base business and delay in commissioning of new projects, we expect HSCL to clock sales, PAT CAGR of 7.0%, 14.3%, respectively, in FY20E-22E. With a decline in margin profile, return ratios matrix has reduced to ~10% RoE, which significantly limits our ability to assign a higher valuation multiple to HSCL. Consequently, we value HSCL at | 50 i.e. 10x P/E on FY22E EPS of | 5.0. We derive some comfort from consistent CFO generation with controlled leverage on B/S (debt: equity at...

Himadri Speciality C.. has an average target of 500.00 from 1 broker.

Himadri Speciality Chemical Ltd.

18 Sep 2019

470.90

-1.23%

Result Update:Himadri Specialt

Buy: Himadri Speciality Chemica...

Target

Axis Direct

Q1FY20: Revenues down by16% Y-o-Y, PAT down by 4% Y-o-Y, led by improving EBIDTA per tonne: In Q1FY20, Himadri Specialty Chemicals Ltd (HSCL) reported revenues of Rs. 524 Cr (down16% Y-o-Y, up 5% Q-o-Q)

Himadri Speciality C.. has an average target of 500.00 from 1 broker.

Himadri Speciality Chemical Ltd.

20 Feb 2019

470.90

-1.23%

Result Update:Himadri Specialt

Buy: Himadri Speciality Chemica...

Target

Axis Direct

In Q3FY19, Himadri Specialty Chemicals Ltd (HSCL) reported revenues of Rs. 587 Cr (up 17% Y-o-Y, flat Q-o-Q), EBITDA of Rs. 148 Cr (up 18% Y-o-Y, up 12% Q-o-Q) with EBITDA/MT of Rs. 15,885 vs Rs. 15,487 Q-o-Q.

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Himadri Speciality Chemical Ltd.

31 Jan 2019

470.90

-1.23%

Himadri Speciality

Buy: Himadri Speciality Chemica...

Target

ICICI Securities Limited

Himadri Speciality Chemicals (HSCL) reported a steady performance in Q3FY19. Total revenues in Q3FY19 came in at | 586.7 crore, up 17% YoY. This was largely realisation led growth given limitations over volume growth due to the planned shutdown Carbon sales volume were at 83,571 units with consequent realisations at | 67,713/tonne. EBITDA in Q3FY19 came in at | 132.8 crore with corresponding EBITDA margins at 22.6%. Consequent EBITDA/tonne was at | 15,900 with PAT at | 84.3 crore, up 20% YoY...

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Himadri Speciality Chemical Ltd.

17 Dec 2018

470.90

-1.23%

Result Update:Himadri Specialt

Buy: Himadri Speciality Chemica...

Target

Axis Direct

In Q2FY19, Himadri Specialty Chemicals Ltd (HSCL) reported revenues of Rs. 602 Cr (up 29% Y-o-Y, flat Q-o-Q), EBITDA of Rs. 132 Cr (up 38% Y-o-Y) with EBITDA/MT of Rs. 15,487 vs Rs. 10,896 Y-o-Y (up 42%). PAT for the quarter stood at Rs. 74 cr (up 45% Y-o-Y). In H1FY19, revenue was up 31% Y-o-Y

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Himadri Speciality Chemical Ltd.

22 Nov 2018

470.90

-1.23%

Himadri Speciality

Buy: Himadri Speciality Chemica...

Target

ICICI Securities Limited

Himadri Speciality Chemicals (HSCL) reported a steady Q2FY19 performance QoQ. Total revenues for the quarter came in at | 601.8 crore, up 29% YoY. Carbon sales volume in Q2FY19 were at 91.6 KT,...

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Himadri Speciality Chemical Ltd.

07 Sep 2018

470.90

-1.23%

Himadri Speciality

Buy: Himadri Speciality Chemica...

Target

ICICI Securities Limited

Himadri Speciality Chemicals (HSCL) reported a robust Q1FY19 performance. Net sales in Q1FY19 were at | 604.7 crore, up 34% YoY largely tracking 28% growth in realisations and 5% growth in volume Carbon sales volume in Q1FY19 were at 99,200 tonne with blended realisations at | 60,467/tonne (94,769 tonne, | 47,264/tonne in Q1'18) EBITDA in Q1FY19 came in at | 135.8 crore with corresponding EBITDA margins at 22.4% (EBITDA/tonne at | 13,685/tonne) PAT in Q1FY19 came in at | 76.7 crore vs. | 50.0 crore in the base...

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Himadri Speciality Chemical Ltd.

09 Apr 2018, 12:00AM

470.90

-1.23%

Pick of the Week:09 APRIL 2018

Buy: Himadri Speciality Chemica...

Target

Axis Direct

Himadri Speciality C.. has an average target of 500.00 from 1 broker.

Himadri Speciality Chemical Ltd.

31 Jan 2018

470.90

-1.23%

Himadri Speciality

Buy: Himadri Speciality Chemica...

ICICI Securities Limited

Himadri Speciality Chemicals (HSCL) reported a robust Q3FY18 performance. Total revenues for the quarter came in at | 500.1 crore, up 42% YoY largely tracking 47.5% growth in realisations amid subdued volume (down 3.3% YoY, annual maintenance shutdown) EBITDA in Q3FY18 came in at | 123.5 crore with corresponding EBITDA margins at 24.7% (EBITDA/tonne at | 13252/tonne) PAT in Q3FY18 came in at | 70.1 crore vs. | 20.1 crore in the base quarter and | 51.2 crore in Q2FY18. Higher PAT was also supported...

Himadri Speciality Chemical Ltd. is trading above all available SMAs

Is Himadri Speciality Chemical Ltd. worth buying?

1503 Votes:

Buy 81.7%

Sell 9.25%

Hold 9.05%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf